Search

Your search keyword '"Springer, Simeon"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Springer, Simeon" Remove constraint Author: "Springer, Simeon"
144 results on '"Springer, Simeon"'

Search Results

1. A novel functional gene delivery platform based on a commensal human anellovirus demonstrates transduction in multiple tissue types

4. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

8. Data from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

9. Supplementary Figure 4 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

10. Supplementary Figure 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

11. Supplementary Figure 5 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

12. Supplementary Table 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

13. Supplementary Table 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

14. Supplementary Figure 3 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

15. Supplementary Figure 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

16. Supplementary Methods, Figure Legends from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

17. Data from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

18. Supplementary Table 1 from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

19. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder

21. Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder

22. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

23. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma

24. Evaluation of Liquid From the Papanicolaou Test and Other Liquid Biopsies for the Detection of Endometrial and Ovarian Cancers

25. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts

27. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

28. Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome

29. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations

30. Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology

31. A multimodality test to guide the management of patients with a pancreatic cyst

32. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations

33. Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

34. MP65-13 UROSEEK: A NOVEL NON-INVASIVE MOLECULAR METHOD FOR EARLY DETECTION OF BLADDER CANCER

35. MP65-14 UROSEEK: A NOVEL NON-INVASIVE MOLECULAR ASSAY FOR SURVEILLANCE OF BLADDER CANCER

36. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

37. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

38. Author response: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

39. Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy

40. Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine

41. 1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS

42. Diagnostic potential of tumor DNA from ovarian cyst fluid

43. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

44. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts

45. Author response: Diagnostic potential of tumor DNA from ovarian cyst fluid

46. The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.

47. 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts

48. A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

49. Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression

50. Abstract 4004: Molecular characterization of circulating glioblastoma cells identifies a mesenchymal-like tumor cell subpopulation

Catalog

Books, media, physical & digital resources